AEON Biopharma (AEON) Insider Trading & Ownership $0.40 +0.01 (+1.28%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$0.39 -0.01 (-3.21%) As of 04/17/2025 05:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock AEON Biopharma (NASDAQ:AEON) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.00%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$73.80 M Get AEON Insider Trade Alerts Want to know when executives and insiders are buying or selling AEON Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AEON Insider Buying and Selling by Quarter AEON Biopharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/11/2023Crown Holdings Grou StrathspeyMajor ShareholderSell102,505$720.00$73,803,600.00 (Data available from 1/1/2013 forward) AEON Insider Trading Activity - Frequently Asked Questions Who is on AEON Biopharma's Insider Roster? The list of insiders at AEON Biopharma includes Crown Holdings Grou Strathspey. Learn more on insiders at AEON. What percentage of AEON Biopharma stock is owned by insiders? 7.00% of AEON Biopharma stock is owned by insiders. Learn more on AEON's insider holdings. Which AEON Biopharma insiders have been selling company stock? The following insider sold AEON shares in the last 24 months: Crown Holdings Grou Strathspey ($73,803,600.00). How much insider selling is happening at AEON Biopharma? Insiders have sold a total of 102,505 AEON Biopharma shares in the last 24 months for a total of $73,803,600.00 sold. AEON Biopharma Key ExecutivesMr. Marc Forth (Age 53)Principal Financial Officer, President, CEO & Director Compensation: $948.75kMr. Alex Wilson (Age 37)Executive VP, Chief Legal Officer & Corporate Secretary Compensation: $517.4kDr. Chad K. Oh M.D. (Age 65)Chief Medical Officer Compensation: $561kMs. Jennifer Sy (Age 39)Principal Accounting Officer More Insider Trading Tools from MarketBeat Related Companies Chemomab Therapeutics Insider Transactions Bullfrog AI Insider Transactions Lipocine Insider Transactions Edesa Biotech Insider Transactions Unity Biotechnology Insider Transactions BriaCell Therapeutics Insider Transactions Eagle Pharmaceuticals Insider Transactions BioVie Insider Transactions Synergy CHC Corp. (Uplisting) Insider Transactions Cingulate Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (NASDAQ:AEON) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AEON Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.